Abstract
Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is an ingredient of chili peppers with inhibitory effects against cancer cells of different origin. We examined the activity of capsaicin on breast cancer cells in vitro and in vivo. The drug potently inhibited growth of ER-positive (MCF-7, T47D, BT-474) and ER-negative (SKBR-3, MDA-MB231) breast cancer cell lines, which was associated with G0/G1 cell-cycle arrest, increased levels of apoptosis and reduced protein expression of human epidermal growth factor receptor (EGFR), HER-2, activated extracellular-regulated kinase (ERK) and cyclin D1. In contrast, cell-cycle regulator p27KIP1, caspase activity as well as poly-ADP ribose polymerase (PARP) cleavage were increased. Notably, capsaicin blocked breast cancer cell migration in vitro and decreased by 50% the size of MDA-MB231 breast cancer tumors growing orthotopically in immunodeficient mice without noticeable drug side effects. in vivo activation of ERK was clearly decreased, as well as expression of HER-2 and cyclin D1, whereas caspase activity and PARP cleavage products were increased in tumors of drug-treated mice. Besides, capsaicin potently inhibited the development of pre-neoplastic breast lesions by up to 80% without evidence of toxicity. Our data indicate that capsaicin is a novel modulator of the EGFR/HER-2 pathway in both ER-positive and -negative breast cancer cells with a potential role in the treatment and prevention of human breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Athanasiou A, Smith PA, Vakilpour S, Kumaran NM, Turner AE, Bagiokou D et al. (2007). Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. Biochem Biophys Res Commun 354: 50–55.
Carraway III KL, Sweeney C . (2006). Co-opted integrin signaling in ErbB2-induced mammary tumor progression. Cancer Cell 10: 93–95.
Chen FL, Wenle Xia W, Spector NL . (2008). Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitors. Clin Cancer Res 14: 6730.
Council of Europe. (2001). Committee of Experts on Flavoring Substances. 48th Meeting Strasbourg, 2–6-April 2001. Document RD 4/2-52. Datasheet on Capsaicin.
Eckert LB, Repasky GA, Ulkü AS, McFall A, Zhou H, Sartor CI et al. (2004). Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res 64: 4585–4592.
Fukazawa H, Noguchi K, Murakami Y, Yoshimasa Uehara Y . (2002). Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway. Mol Cancer Ther 1: 303–309.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN . (2007). Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608: 1–22.
Hail N, Lotan R . (2002). Examining the role of mitochondrial respiration in vanilloid-induced apoptosis. J Natl Cancer Inst 94: 1281–1292.
Ito K, Nakazato T, Yamato K, Miyakawa Y, Yamada T, Hozumi N et al. (2004). Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res 64: 1071–1078.
Johnson Jr W . (2007). Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol 26: 3–106.
Jung MY, Kang HJ, Moon A . (2001). Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and capsase-3 activation. Cancer Lett 165: 139–145.
Kawada M, Yamagoe S, Murakami Y, Suzuki K, Mizuno S, Uehara Y . (1997). Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15: 629–637.
Kim CS, Park WH, Park JY, Kang JH, Kim MO, Kawada T et al. (2004). Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. J Med Food 7: 267–273.
Korkaya H, Paulson A, Iovino F, Wicha MS . (2008). HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27: 6120–6130.
Krueger JS, Keshamouni VG, Atanaskova N, Reddy KB. (2001). Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion. Oncogene 20: 4209–4218.
Kumagai T, O’Kelly J, Said JW, Koeffler HP . (2003). Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst 95: 896–905.
Lavoie JN, Rivard N, L’Allemain G, Pouysségur J . (1996). A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog Cell Cycle Res 2: 49–58.
Lo YC, Yang YC, Wu IC, Kuo FC, Liu CM, Wang HW et al. (2005). Capsaicin-induced cell death in a human gastric adenocarcinoma cell line. World J Gastroenterol 11: 6254–6257.
Magkou C, Nakopoulou L, Zoubouli C, Karali K, Theohari I, Bakarakos P et al. (2008). Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas. Breast Cancer Res 10: R49.
Mehta RG, Bhat KP, Hawthorne ME, Kopelovich L, Mehta RR, Christov K et al. (2001). Induction of atypical hyperplasia in mouse mammary gland organ culture. J Natl Cancer Inst 93: 1103–1106.
Mehta RG, Williamson E, Patel M, Koeffler HP . (2000). PPARγ ligand and retinoids prevent pre-neoplastic mammary lesions. J Natl Cancer Inst 92: 418–423.
Ménard S, Pupa SM, Campiglio M, Tagliabue E . (2003). Biologic and therapeutic role of HER2 in cancer. Oncogene 22: 6570–6578.
Mendelsohn J, Baselga J . (2000). The EGF receptor family as targets for cancer therapy. Oncogene 19: 6550–6565.
Mendelsohn J, Baselga J . (2003). Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21: 2787–2799.
Monsereenusorn Y, Kongsamut S, Pezella PD . (1982). Capsaicin: a literature survey. Crit Rev Toxicol 10: 321–339.
Montgomery RB, Makary E, Schiffman K, Goodell V, Disis ML . (2005). Endogenous anti-HER2 antibodies block HER2 phosphorylation and signaling through extracellular signal-regulated kinase. Cancer Res 65: 650–656.
Mori A, Lehmann S, O’Kelly J, Kumagai T, Desmond JC, Pervan M et al. (2006). Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 66: 3222–3229.
Morre DJ, Chueh PJ, Morre DM . (1995). Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci USA 92: 1831–1835.
Morris GJ, Mitchell EP . (2008). Higher incidence of aggressive breast cancers in African-American women: a review. J Natl Med Assoc 100: 698–702.
Rock E, DeMichele A . (2003). Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. J Nutr 133: 3785–3793.
Sánchez AM, Sánchez MG, Malagarie-Cazenave S, Olea N, DÃaz-Laviada I . (2006). Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis 11: 89–99.
Scaltriti M, Baselga J . (2006). The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res 12: 5268–5272.
Schafer JM, Bentrem DJ, Takei H, Gajdos C, Badve S, Jordan VC . (2002). A mechanism of drug resistance to tamoxifen in breast cancer. J Steroid Biochem Mol Biol 83: 75–83.
Sivaraman VS, Wang H, Nuovo GJ, Malbon CC . (1997). Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 99: 1478–1483.
Solit DB, Zheng FF, Drobnjak M, Münster PN, Higgins B, Verbel D et al. (2002). 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. Clin Cancer Res 8: 986–993.
Taik-koo Y . (1999). Update from Asia: Asian studies on cancer chemoprevention. Ann NY Acad Sci 889: 157–192.
Tuoya, Baba N, Shimoishi Y, Murata Y, Tada M, Koseki M et al. (2006). Apoptosis induction by dohevanil, a DHA substitutive analog of capsaicin, in MCF-7 cells. Life Sci 78: 1515–1519.
Acknowledgements
NH Thoennissen's work was supported by the Deutsche Forschungsgemeinschaft, Bonn, Germany (TH 1438/1-1); B Karlan by the Woman Cancer Institute of Cedars-Sinai Medical Center, Los Angeles, CA, USA and GB Iwanski by the Jung-Stiftung für Wissenschaft und Forschung, Hamburg, Germany. HP Koeffler is the holder of the Mark Goodson endowed Chair in Oncology Research and is a member of the Jonsson Cancer and Molecular Biology Institute, UCLA, Los Angeles, CA, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thoennissen, N., O'Kelly, J., Lu, D. et al. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene 29, 285–296 (2010). https://doi.org/10.1038/onc.2009.335
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.335
Keywords
This article is cited by
-
Arvanil induces ferroptosis of hepatocellular carcinoma by binding to MICU1
Cancer Gene Therapy (2023)
-
Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin)
Scientific Reports (2023)
-
Co-targeting of EGFR by co-expressed miRNA-193a-3p/−5p in lung cancer
ExRNA (2019)
-
Role of Autophagy in Capsaicin-Induced Apoptosis in U251 Glioma Cells
Cellular and Molecular Neurobiology (2016)
-
Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals
Targeted Oncology (2015)